3D Global Biotech (ROCO:6808) Beta: 0.3403 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6808 3D Global Biotech Inc ROCO:6808
70 GF Score
Price NT$38.85
GF Value NT$185.91
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is 3D Global Biotech Beta?

3D Global Biotech ROCO:6808 -3.00% 70 Beta is 0.3403 as of Jul. 18, 2026. GuruFocus rates ROCO:6808 with a GF Score™ of 70/100 and a GF Value™ of NT$185.91 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-18), 3D Global Biotech's Beta is 0.3403.


3D Global Biotech  (ROCO:6808) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


3D Global Biotech Beta Related Terms


3D Global Biotech Beta Historical Data

* Premium members only.

The historical data trend for 3D Global Biotech's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3D Global Biotech Beta Chart

3D Global Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.46 0.77 0.00

3D Global Biotech Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.71 0.77 0.00 0.00

ROCO:6808 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, 3D Global Biotech's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3D Global Biotech Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Global Biotech's Beta distribution charts can be found below:

* The bar in red indicates where 3D Global Biotech's Beta falls into.


ROCO:6808
70GF Score
3D Global Biotech Inc ROCO:6808
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3D Global Biotech Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3403 mean?
3D Global Biotech (ROCO:6808) has a Beta of 0.3403 as of Jul. 18, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for 3D Global Biotech and its competitors.
Is 3D Global Biotech's Beta too high?
3D Global Biotech's current Beta is 0.3403. Overall, 3D Global Biotech has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 3D Global Biotech's Beta compare to VRTX and REGN?
3D Global Biotech's Beta of 0.3403 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for 3D Global Biotech and its competitors. 3D Global Biotech's current Beta is 0.3403. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3D Global Biotech stock overvalued right now?
Based on GuruFocus' analysis, 3D Global Biotech (ROCO:6808) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$185.91, compared to a current price of NT$38.85 — trading 79.1% below its estimated fair value. The current Beta is 0.3403. 3D Global Biotech's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For 3D Global Biotech (ROCO:6808), the current Beta is 0.3403 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3D Global Biotech (ROCO:6808) Overvalued in 2026?

Based on GuruFocus' analysis, 3D Global Biotech stock appears to be undervalued. The current stock price of NT$38.85 is trading 79.1% below its estimated GF Value™ of NT$185.91. GuruFocus considers 3D Global Biotech to be Significantly Undervalued.

Key valuation signals for ROCO:6808:

  • Beta: 0.3403
  • GF Value™: NT$185.91 vs. price of NT$38.85 (79.1% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6808 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


3D Global Biotech Business Description

Address No.99, Section 1, Xintai 5th Road, 21st Floor -3, Xizhi District, New Taipei, TWN, 221
3D Global Biotech Inc is engaged in the research and development of high-end medical equipment and biological 3D printing technology and the sale of medical Materials and other related products.
70GF Score

Get the complete analysis for ROCO:6808

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.85
Price
NT$185.91
GF Value